ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 052,84
-0,15%
Dow Jones
38 386,09
0,00%
DAX
18 045,59
-0,48%
Brent Oil
87,675
0,45%
Bitcoin
60 992,33
-4,46%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avenue Therapeutics Inc (ATXI)

  7. Avenue Therapeutics Inc (ATXI) Actualités

ATXI Avenue Therapeutics Inc

4,30
-0,2147 (-4,76%)
Avant marché
Dernière mise à jour : 14:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Avenue Therapeutics Inc ATXI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,2147 -4,76% 4,30 14:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,5147
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202414:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
24/4/202413:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
25/3/202413:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
18/3/202421:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/3/202413:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/3/202413:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
08/3/202422:31EDGAR2Form PRE 14C - Other preliminary information statements
08/3/202422:15EDGAR2Form 8-K - Current report
22/2/202414:30GLOBEAvenue Therapeutics Announces Publication in Drug..
02/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
29/1/202414:00EDGAR2Form DEF 14C - Other definitive information statements
24/1/202422:11EDGAR2Form S-3 - Registration statement under Securities Act of..
17/1/202423:05EDGAR2Form PRE 14C - Other preliminary information statements
12/1/202412:01EDGAR2Form 8-K - Current report
11/1/202414:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
08/1/202423:28EDGAR2Form 8-K - Current report
05/1/202415:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
04/1/202414:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
02/1/202414:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
13/12/202322:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/12/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202314:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
28/11/202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/11/202322:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202319:19EDGAR2Form 8-K - Current report
13/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
02/11/202321:10EDGAR2Form 8-K - Current report
02/11/202320:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202314:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/10/202314:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
05/10/202323:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
29/9/202323:23EDGAR2Form S-1/A - General form for registration of securities..
28/9/202322:25EDGAR2Form 8-K - Current report
27/9/202322:03EDGAR2Form 8-K - Current report
18/9/202323:18EDGAR2Form S-1 - General form for registration of securities under..
08/9/202322:15EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
14/8/202322:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
11/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:20EDGAR2Form 8-K - Current report
10/8/202322:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/8/202314:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/7/202314:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/7/202314:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
21/7/202322:37EDGAR2Form 8-K - Current report
05/7/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ATXI
Avenue Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés